Quanterix: Cheap on an EV/Sales Basis — a Tactical Long with Defined Risk
Quanterix (QTRX) trades near $3.84 with an enterprise value roughly equal to one year of sales. The hardware and ultra-sensitive biomarker franchise gives the company an asymmetric setup: meaningful upside if clinical and commercial adoption continues, limited near-term downside if a deal or improving sales re-rate multiples. This is a tactical lon…